These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29444744)

  • 1. Overexpression of Pyruvate Dehydrogenase E1α Subunit Inhibits Warburg Effect and Induces Cell Apoptosis Through Mitochondria-Mediated Pathway in Hepatocellular Carcinoma.
    Sun J; Li J; Guo Z; Sun L; Juan C; Zhou Y; Gu H; Yu Y; Hu Q; Kan Q; Yu Z
    Oncol Res; 2019 Mar; 27(4):407-414. PubMed ID: 29444744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyruvate dehydrogenase expression is negatively associated with cell stemness and worse clinical outcome in prostate cancers.
    Zhong Y; Li X; Ji Y; Li X; Li Y; Yu D; Yuan Y; Liu J; Li H; Zhang M; Ji Z; Fan D; Wen J; Goscinski MA; Yuan L; Hao B; Nesland JM; Suo Z
    Oncotarget; 2017 Feb; 8(8):13344-13356. PubMed ID: 28076853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells.
    Glushakova LG; Lisankie MJ; Eruslanov EB; Ojano-Dirain C; Zolotukhin I; Liu C; Srivastava A; Stacpoole PW
    Mol Genet Metab; 2009 Nov; 98(3):289-99. PubMed ID: 19586787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ilimaquinone Induces the Apoptotic Cell Death of Cancer Cells by Reducing Pyruvate Dehydrogenase Kinase 1 Activity.
    Kwak CH; Jin L; Han JH; Han CW; Kim E; Cho M; Chung TW; Bae SJ; Jang SB; Ha KT
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin induces phosphorylation of pyruvate dehydrogenase through RhoA activation pathway in HepG2 cells.
    Islam R; Kim JG; Park Y; Cho JY; Cap KC; Kho AR; Chung WS; Suh SW; Park JB
    FASEB J; 2019 Feb; 33(2):2072-2083. PubMed ID: 30226812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT3 elicited an anti-Warburg effect through HIF1α/PDK1/PDHA1 to inhibit cholangiocarcinoma tumorigenesis.
    Xu L; Li Y; Zhou L; Dorfman RG; Liu L; Cai R; Jiang C; Tang D; Wang Y; Zou X; Wang L; Zhang M
    Cancer Med; 2019 May; 8(5):2380-2391. PubMed ID: 30993888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT3 deacetylates and increases pyruvate dehydrogenase activity in cancer cells.
    Ozden O; Park SH; Wagner BA; Song HY; Zhu Y; Vassilopoulos A; Jung B; Buettner GR; Gius D
    Free Radic Biol Med; 2014 Nov; 76():163-172. PubMed ID: 25152236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma.
    Zhao C; Wang B; Liu E; Zhang Z
    Cell Commun Signal; 2020 Aug; 18(1):131. PubMed ID: 32831114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
    PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR‑21‑5p targets PDHA1 to regulate glycolysis and cancer progression in gastric cancer.
    Liu Z; Yu M; Fei B; Fang X; Ma T; Wang D
    Oncol Rep; 2018 Nov; 40(5):2955-2963. PubMed ID: 30226598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyr-301 phosphorylation inhibits pyruvate dehydrogenase by blocking substrate binding and promotes the Warburg effect.
    Fan J; Kang HB; Shan C; Elf S; Lin R; Xie J; Gu TL; Aguiar M; Lonning S; Chung TW; Arellano M; Khoury HJ; Shin DM; Khuri FR; Boggon TJ; Kang S; Chen J
    J Biol Chem; 2014 Sep; 289(38):26533-26541. PubMed ID: 25104357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.
    Weng Q; Chen M; Yang W; Li J; Fan K; Xu M; Weng W; Lv X; Fang S; Zheng L; Song J; Zhao Z; Fan X; Ji J
    FASEB J; 2020 Apr; 34(4):5420-5434. PubMed ID: 32080912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
    Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
    Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
    PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway.
    Xu S; Shu P; Zou S; Shen X; Qu Y; Zhang Y; Sun K; Zhang J
    Cancer Med; 2018 Sep; 7(9):4701-4717. PubMed ID: 30085405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexokinase II promotes the Warburg effect by phosphorylating alpha subunit of pyruvate dehydrogenase.
    Luo F; Li Y; Yuan F; Zuo J
    Chin J Cancer Res; 2019 Jun; 31(3):521-532. PubMed ID: 31354221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of Pyruvate Metabolic Fates Modulates Head and Neck Tumorigenesis.
    Chen TY; Hsieh YT; Huang JM; Liu CJ; Chuang LT; Huang PC; Kuo TY; Chia HY; Chou CY; Chang CW; Chen YF; Chen HM; Lo JF; Li WC
    Neoplasia; 2019 Jul; 21(7):641-652. PubMed ID: 31100640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncoprotein HBXIP promotes glucose metabolism reprogramming via downregulating SCO2 and PDHA1 in breast cancer.
    Liu F; Zhang W; You X; Liu Y; Li Y; Wang Z; Wang Y; Zhang X; Ye L
    Oncotarget; 2015 Sep; 6(29):27199-213. PubMed ID: 26309161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.